D
Emergent BioSolutions Inc. EBS
$8.71 -$0.49-5.33% NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -117.65% 317.25% -127.26% 140.55% -3,245.56%
Total Depreciation and Amortization -7.48% -2.31% -1.52% -7.37% 2.15%
Total Amortization of Deferred Charges 4.35% 4.55% 132.84% -234.00% -27.54%
Total Other Non-Cash Items -127.12% 38.82% 118.32% -150.88% 1,124.72%
Change in Net Operating Assets 180.62% -39.16% -230.03% -68.14% 311.18%
Cash from Operations 1,050.00% 85.98% -151.98% 223.58% 175.88%
Capital Expenditure 19.44% -111.76% 70.69% -26.09% 57.41%
Sale of Property, Plant, and Equipment -70.48% 22,600.00% -96.05% -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -100.00% -- --
Other Investing Activities 100.00% -116.67% -- -- --
Cash from Investing -71.09% 108.04% -74.46% 2,534.78% 57.41%
Total Debt Issued -- -- -100.00% 1,360.00% -70.00%
Total Debt Repaid -- -- 100.00% -582.64% -579.78%
Issuance of Common Stock 600.00% -87.50% -91.40% 1,228.57% --
Repurchase of Common Stock -1,320.00% -66.67% 0.00% -50.00% 50.00%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -100.00% 179.66% --
Cash from Financing -1,500.00% -180.00% 100.28% -254.22% -225.06%
Foreign Exchange rate Adjustments 242.86% -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 150.42% 192.91% -159.48% 1,167.50% 75.54%